Muga First pass

Last Updated: 1/27/2020

Purpose:        
In first-pass radionuclide angiocardiography, a bolus of radioactivity is injected into a peripheral vein, and the initial transit of the bolus through the heart, lungs, and great vessels is imaged in rapid sequence using a gamma camera.  Computer collection of the data allows for the quantitative analysis of the images including right ventricular ejection fraction.  In addition, anatomic images can be obtained for visual interpretation.
 
Patient Preparation: None.
 
Contraindications: Recent nuclear medicine procedures. Pregnant females (if the patient is pregnant or is unsure of her pregnancy status, consult with a nuclear medicine physician immediately).
 
Radiopharmaceutical:
 

  1. Invitro method (Preferred):     25mCi Tc99m Ultratag RBCs (preferred).
  2. Invivo method:                       25 mCi Tc04 used with 6 mg “cold” Sn PYP.
 
Normal Adult Dose: 25 mCi Tc99m Ultratag RBCs.  (If using PYP, QS the Tc04 with NaCl to 3ml).
 
Method of Administration: Bolus intravenous injection over 3 – 5 second steady push.  Inject in Rt AC or higher.

Injection–To–Imaging Time:           Immediate.
 
Conflicting Examinations/Medications:      None.
 
Technique:
  1. Prepare Tc99m Ultratag RBCs according to the package insert inside the UltraTag kit. If using cold PYP, then follow the instructions inside the PYP kit.
  2. Position the patient and attach the three EKG leads appropriately.
  3. Acquire a gated dynamic acquisition in an RAO projection. Timing is critical, so start the acquisition before injecting or have another technologist start it the soon as the injection begins.
    1. 64x64 matrix, 1000 frames at 0.03 seconds per frame, Zoom: 1.45